Recent
News
-
Intelligent
Bio-Systems,
Inc.
April 6, 2011
IBS' Proprietary Sequencing Technology
featured in NHGRI Conference.
CEO and Founder Dr. Steven Gordon is a principal investigator in a
National Human Genome Research Institute (NHGRI) grant for the
development of advanced sequencing technology (see Sept. 14, 2010 news
below). He described some of the Company's work in a key meeting of
sequencign technlogy developers in San Diego.
read
more
March 18, 2011
IBS's New Diagnostic Sequencing System
Unveiled during XGEN Conference.
CEO
and
Founder,
Dr.
Steven
Gordon described the unique design and significant cost and performance
advantages of IBS's new MINI sequencer for research and diagnostic
applications.
read more
September 14, 2010
IBS Awarded $2.6
Million NIH Grant as Part of the $1,000 Genome Initiative
from the National
Human Genome Research Institute for "Third Generation DNA
Sequencing Technology."
read more
February 8, 2011
New US Patent 7,883,869 issued as part of IBS's exclusively
licensed IP portfolio. IBS' Founder,
Dr.
Jingyue Ju and his team at Columbia University were awarded a US patent
entitled "Four-color DNA sequencing by synthesis using cleavable
fluorescent nucleotide reversible terminators" related on the use of a
unique method for reducing the cost of next generation sequencing by
synthesis.
read
more
September 7, 2010
New US Patent 7,790,869 issued as part of IBS' exclusively licensed
IP Protfolio. Company's Founder, Dr.
Jingyue Ju and his team at Columbia University were awarded a US patent
entitled "Massive parallel method for decoding DNA and RNA" related on
the use of cleavable blocking groups and dyes using almost any cleaving
method.
read
more
January 15, 2007
